Integra Lifesciences Analyst Ratings
BTIG Sticks to Its Hold Rating for Integra Lifesciences (IART)
Buy Rating on Integra Lifesciences Amidst Recovery and Growth Prospects
Integra Lifesciences: Sell Rating Justified by Underwhelming Financials and Leadership Concerns
Analysts Offer Insights on Healthcare Companies: Mirum Pharmaceuticals (MIRM) and Integra Lifesciences (IART)
Analysts Are Bullish on These Healthcare Stocks: Bausch + Lomb Corporation (BLCO), Integra Lifesciences (IART)
Integra Lifesciences (IART) Receives Buy Rating Following FDA Approval of CereLink Monitors
Analysts Offer Insights on Healthcare Companies: Streamline Health Solutions (STRM), MiMedx Group (MDXG) and Integra Lifesciences (IART)
Integra Lifesciences Analyst Ratings
Integra Lifesciences Analyst Ratings
Wells Fargo Upgrades Integra Lifesciences to Overweight, Raises Price Target to $49
Integra Lifesciences Analyst Ratings
Integra Lifesciences Analyst Ratings
Analysts Have Conflicting Sentiments on These Healthcare Companies: Integra Lifesciences (IART) and Revvity (RVTY)
Integra Lifesciences Analyst Ratings
Integra Lifesciences' Underperformance and Recall Issues Prompt Sell Rating: An Analysis by Joanne Wuensch
Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS), Merck & Company (MRK) and Integra Lifesciences (IART)
Hold Rating for Integra Lifesciences Amid Mixed Financial Outlook and Boston Facility Setbacks
Analysts Have Conflicting Sentiments on These Healthcare Companies: Akebia Therapeutics (AKBA) and Integra Lifesciences (IART)
Morgan Stanley Bullish on SI-Bone, Downgrades Stevanato, Integra, Agiliti
No Data